The board of directors of China Resources Medical Holdings Company Limited announced that Ms. FU Yanjun (Ms. FU) has resigned, with effect from December 30, 2021, as an executive Director due to other work arrangement within the Group. Ms. FU has confirmed that she has no disagreement with the Board and that there is no matter in respect of her resignations which needs to be brought to the attention of the shareholders of the Company and The Stock Exchange of Hong Kong Limited. The Board announced that Mr. SHAN Baojie (Mr. SHAN) has been re-designated from the role of non-executive Director to executive Director with effect from December 30, 2021. Mr. SHAN has been appointed as the non-executive director of the Company on August 25, 2021, and he is also currently the vice general manager of China Resources Healthcare Group Limited (``CR Healthcare''), the Company's controlling shareholder, and is also taking the office as a director of a number of its subsidiaries. CR Healthcare, as one of the primary healthcare platforms of the China Resources Group, is specialised in the investment and operations management in the healthcare industry. CR Healthcare is committed to the long-term development of China's medical and healthcare services, actively participates in China's medical system reform, and proactively explores and involves in the investment, operation and management of hospitals and healthcare industries in the PRC. In addition to being the single largest shareholder of the Company, CR Healthcare also operates and manages a number of medical institutions in certain provinces of China including Liaoning, Jiangxi, Yunnan and Guangdong and Guangxi, etc. Prior to joining CR Healthcare, Mr. SHAN was with the Group from 2011 to 2016 as the executive general manager and then the vice general manager, and he was also an executive Director of the Company from February 2016 to November 2016. The Board announces that Mr. HU Hui (``Mr. HU'') has been appointed as a non-executive Director and a member of the Audit Committee with effect from December 30, 2021. Mr. HU currently serves as the general manager of the Legal and Compliance Department (and Assets Management Department) of CR Healthcare (the controlling shareholder of the Company) and is also taking the office as a director of a number of its subsidiaries. He was previously the Senior Director of the Device Division of CR Healthcare (then named China Resources Medical Group Co. Ltd.) from November 2011 to November 2014, the General Manager of the Legal Department of CR Healthcare from November 2014 to November 2019, and the head of the Comprehensive Management Department of CR Healthcare from November 2019 to December 2020. The Board announces that Mr. CHENG Libing has resigned as a member of the nomination committee of the Company (Nomination Committee), Mr. LEE Kar Chung Felix has resigned as the chairman of the Nomination Committee and remains as a member of the Nomination Committee, and Mr. SONG Qing has been appointed as the chairman of the Nomination Committee with effect from December 30, 2021. The Board announces that Mr. SHAN Baojie has resigned as a member of the audit committee of the Company (Audit Committee) and Mr. HU Hui has been appointed as a member of the Audit Committee with effect from December 30, 2021.